Login
Clinical user conference

User Conference Agenda.

9:00 AM ET

Better, Faster, Simpler - accelerating breakthroughs with genetic testing

Speaker: Jamie Littlejohns, Chief Executive Officer at Velsera

Welcome to the Velsera User Conference, an exclusive event bringing together top experts and innovators in precision medicine. Velsera is at the forefront of pioneering technology-driven solutions that foster seamless knowledge flow across biopharma and healthcare. Throughout the conference, you will gain insights into Velsera's bold vision and innovative approach to precision medicine and genetic testing. Join us for inspiring keynote sessions, dynamic panel discussions, and opportunities to engage with thought leaders shaping the future of healthcare.

9:50 AM ET

CGW Plus: The Evolution of CGW

Speakers:  Sohini Sengupta, PhD, Senior Product Manager at Velsera

 In this presentation, we will highlight the common challenges of comprehensive molecular reporting with NGS assays and decades of customer use and feedback that led to the evolution of CGW to the re-imagined CGW Plus. We will demonstrate the major features that CGW Plus has to offer. CGW Plus offers advanced variant quality and clinical evidence review workflows, as well as adaptive learning and memory features. CGW Plus is designed to simplify and accelerate the analysis and reporting of genomic sequence data for clinical laboratory professionals, by enabling your team to focus on delivering the best patient care possible. The platform is designed to save your team time without compromising on clinical quality. 

10:40 AM ET

Positive NGS reimbursement trends: GSP CPT coding & pricing and expanding biomarker laws

Speaker: Jonathan Anderson, National Director of Laboratory Operations at Solaris Health & Sarah Clancey Overton, Director of Revenue Cycle Management at Velsera

Join us for this Revenue Cycle Management fireside chat between Jonathan Anderson of IMP and Sarah Clancey Overton of Velsera. Jonathan will share the Solaris Group's overall experience with aligned validation and MolDX submission for its affiliates as well as discussing CPT coding, coverage and policy support for their expanded gene panel and partnering to maximize reimbursement for individual payers. Sarah will also give a brief update on some key NGS reimbursement developments around MolDX, CPT coding and biomarker laws.

11:30 AM ET

CGW Secondary Analysis Now Powered by the Seven Bridges Genomics Platform

Speaker: Jason Peterson, Director of Product Management at Velsera

Technological advances in Next-generation sequencing (NGS) have dramatically increased the amount of genomic data that can be generated, while simultaneously driving significant reductions in cost.  These advances have promoted the broad adoption of NGS as an essential tool in clinical diagnostics and modern medicine.  However, while NGS is increasingly utilized in clinical practice - significant challenges still exist in analyzing and interpreting large volumes of genomic data.  
For this reason, Velsera has brought together the Clinical Genomics Workspace (CGW) and the Seven Bridges Genomics (SBG) platforms.  With this integration, Velsera customers are now able to utilize the powerful and flexible secondary analysis features of the SBG platform in conjunction with the best-in-class tertiary analysis and reporting solutions offered by the CGW platform. 
In this presentation, we will highlight the exciting new capabilities supported through this integration including ready-to-use productized assay workflows, support for hosting existing pipelines in a highly reliable & scalable environment, and custom pipeline development and optimization.   

12:20 PM ET

Your Success is Ours

Speaker: Julie Furt, Chief Customer Officer at Velsera

Stay with us until the end, when I plan to unveil key initiatives Velsera is rolling out to support all our customers. New services methodology, knowledge management and training, and more! 

 

Event Moderator: Rakesh Nagarajan, MD, PhD, Chief Medical Officer at Velsera

Meet Velsera's team: 

Jamie joined Velsera in January 2024, having previously provided external support to Velsera and their founding business since early 2022. He has worked in healthcare and life sciences since 2010 and previously was a Partner at McKinsey & Company where he spent over a decade and led their Health & Life Science Investing Practice in Europe, specializing in supporting investor-backed health & life science tech businesses on their scale-up journeys.

Jamie

Jamie Littlejohns 

Chief Executive Officer 

Rakesh (2)

Rakesh Nagarajan, MD, PhD

Chief Medical Officer

 

Dr. Nagarajan has been a pioneer in genomics and informatics for 20+ years. He started at Washington University, the first CAPCLIA laboratory for clinical NGS, and where he facilitated clinical and translational research by integrating EHR, clinical trials, patient registry, biospecimen, and genomics data and by supporting complex multimodal analyses across these data types. As the Founder and President of Pierian, he built the Clinical Genomics Workspace (CGW), an end-to-end disease, assay, and instrument agnostic informatics solution used to process clinical NGS cases. At Velsera, Dr. Nagarajan leads the Knowledgebase team, which is responsible for curated clinical content that supports tertiary analysis in the CGW, and is responsible for regulatory submissions and for incubating and developing technology solutions to extend Velseras reach.

 

Julie has extensive experience managing high-growth, high-performing global customer success teams and has worked with clients across a variety of industries, including life sciences, healthcare, and government. She has particular interest in nurturing partnerships with clients, customer success management, and customer value realization. 

Julie (2)

Julie Furt 

Chief Customer Officer